News

UnitedHealth Is Approaching a Pivotal Moment. Should Investors Buy the Stock Before July 29?
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
UnitedHealth Stock Is Dropping. Inside the Earnings Release Worrying Investors.
UnitedHealth Group set a new full-year earnings target Tuesday morning that was far below Wall Street expectations, but hints ...
UnitedHealth’s stock falls to five-year low as outlook was reinstated but missed expectations
The health insurance giant’s second-quarter profit missed expectations as it continues to face higher medical costs.
An Unpopular Pick: 5 Reasons Why Buying UnitedHealth Group Stock Now Could Be a Brilliant Move
UnitedHealth Group is also moving forward with cost-cutting initiatives to boost its bottom line. CEO Stephen Hemsley ...
Here's How Much UnitedHealth Group Stock Is Expected to Move After Earnings
UnitedHealth Group is scheduled to report second-quarter results ahead of the opening bell on Tuesday, with markets expecting ...
UnitedHealth falls short of second quarter expectations and offers weak outlook for 2025
UnitedHealth delivered disappointing second-quarter earnings and went conservative with its 2025 forecast as soaring medical ...
UnitedHealth Stock Is A Strong Buy Amid Unfavorable Medical Trends (Upgrade)
UnitedHealth Group is positioned for long-term growth despite challenges, with resilient fundamentals. Click for my updated ...
UnitedHealth Group Stock Opens at 5-Year Low as Profit Disappoints
Shares of UnitedHealth Group opened at their lowest point since early 2020 as the health insurance giant's second-quarter ...
UnitedHealth Group stock price drops again as the health insurance giant’s sickly summer continues
Rising costs and a run of bad news have prompted shares to fall more than 44% this year. Here’s what’s causing the latest ...
UnitedHealth Shares Slide Over 5% After Baird Downgrade And Price Target Cut
UnitedHealth Group Inc. (NYSE: UNH) shares are trading lower Thursday, after Baird downgraded the stock to Underperform and slashed its price target from $312 to $198.